What is the status of clinical trials in Finland? – Views of neuroresearchers and pharma industry
Neurocenter Finland invites all stakeholders including medical students, doctoral and PhD -students (neuroscience), researchers (basic, translational, clinical), clinicians, CRO’s, pharma industry and other service providers to join the conversation in online workshop 14th Dec 2022 at 3-6 pm.
The aim of this workshop is to identify bottle necks and supporting activities needed to develop collaboration and increase the number of clinical trials in Finland in the field on neurosciences. Also, by reducing the translational gap we can improve the success rate of the clinical trials and novel therapies enabling better treatments for the patients.
Riikka Siurola, Roche and Eero Rissanen, Neurocenter Finland: Good Clinical Practice (GCP) – is this still reachable? Roles and responsibilities of clinicians in clinical trials and Reality from clinicians’ point of view
Tanja Hakkarainen, Novartis and Filip Scheperjans, HUS: How to match supply and demand – bringing together the right researchers and clinical trials
Break 10 min.
Mika Scheinin, CRST Oy: Clinical trials at a dedicated research unit – 25 years of experience
Eino Solje, Brain Research Unit (UEF): Visions for the future-experiences from international initiatives for rare neurodegenerative disorders
Sanna Lauslahti and Mia Bengström, Lääketeollisuus ry: Let’s go to the future together!